The Leukemia & Lymphoma Society (LLS) and FORMA Therapeutics, Inc. today announced they have begun a partnership to discover and develop small molecule compounds against a key lymphoma target, Bcl-6....
Read More...
[Source: Society News]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment